Open access · CC-BY
via OpenAlex
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure
Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra, Massimo Andreatta, Yi-Hsuan Chiang, Catherine Ronet, Christine Pich-Bavastro, Jesús Corría-Osorio, François Kuonen, Johan H. Auwerx, Patrizia D’Amelio, Ping‐Chih Ho, Santiago J. Carmona, George Coukos, Denis Migliorini
Nature Cancer · 2025 · ▲ 55 citations
Abstract
Chimeric antigen receptor (CAR) T cell therapy is one of the most promising cancer treatments. However, different hurdles are limiting its application and efficacy. In this context, how aging influences CAR-T cell outcomes is largely unknown. Here we show that CAR-T cells generated from aged female mice present a mitochondrial dysfunction(definition) derived from nicotinamide adenine dinucleotide (NAD) depletion that leads to poor stem-like properties and limited functionality in vivo. Moreover, human data analysis revealed that both age and NAD metabolism determine the responsiveness to CAR-T cell therapy. Targeting NAD pathways, we were able to recover the mitochondrial fitness and functionality of CAR-T cells derived from older adults. Altogether, our study demonstrates that aging is a limiting factor to successful CAR-T cell responses. Repairing metabolic and functional obstacles derived from age, such as NAD decline, is a promising strategy to improve current and future CAR-T cell therapies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s43018-025-00982-7
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Hope, H.C., Sostoa, J.D., Ginefra, P., Andreatta, M., Chiang, Y., Ronet, C., Pich-Bavastro, C., Corría-Osorio, J., Kuonen, F., Auwerx, J.H., D’Amelio, P., Ho, P., Carmona, S.J., Coukos, G., Migliorini, D., & Vannini, N. (2025). Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure. <em>Nature Cancer</em>. https://doi.org/10.1038/s43018-025-00982-7
Vancouver
Hope HC, Sostoa JD, Ginefra P, Andreatta M, Chiang Y, Ronet C, et al. Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure. Nature Cancer. 2025. doi:10.1038/s43018-025-00982-7.
BibTeX
@article{helen2025Ageass,
title = {Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure},
author = {Helen Carrasco Hope and Jana de Sostoa and Pierpaolo Ginefra and Massimo Andreatta and Yi-Hsuan Chiang and Catherine Ronet and Christine Pich-Bavastro and Jesús Corría-Osorio and François Kuonen and Johan H. Auwerx and Patrizia D’Amelio and Ping‐Chih Ho and Santiago J. Carmona and George Coukos and Denis Migliorini and Nicola Vannini},
journal = {Nature Cancer},
year = {2025},
doi = {10.1038/s43018-025-00982-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Cell and Developmental Biology 2024
Open access · CC-BY
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
World Journal of Stem Cells 2019
Open access · CC-BY
Aging: A cell source limiting factor in tissue engineering
Hematology/Oncology and Stem Cell Therapy 2017
Open access · CC-BY
Aging and stem cell therapy: AMPK as an applicable pharmacological target for rejuvenation of aged stem cells and achieving higher efficacy in stem cell therapy
Current Opinion in Hematology 2008
Preprint · OA
Sirtuin 1, stem cells, aging, and stem cell aging
InTech eBooks 2018
Open access · CC-BY
Stem Cell Aging
Cell stem cell 2023
Open access · CC-BY